SANOFI (SAN.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:SAN • FR0000120578

81.09 EUR
-0.75 (-0.92%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

5

Taking everything into account, SAN scores 5 out of 10 in our fundamental rating. SAN was compared to 55 industry peers in the Pharmaceuticals industry. While SAN is still in line with the averages on profitability rating, there are concerns on its financial health. SAN is not valued too expensively and it also shows a decent growth rate. SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SAN had positive earnings in the past year.
  • In the past 5 years SAN has always been profitable.
  • Each year in the past 5 years SAN had a positive operating cash flow.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SAN has a better Return On Assets (10.63%) than 76.36% of its industry peers.
  • With a decent Return On Equity value of 18.84%, SAN is doing good in the industry, outperforming 61.82% of the companies in the same industry.
  • The Return On Invested Capital of SAN (13.35%) is better than 65.45% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SAN is significantly below the industry average of 14.23%.
  • The 3 year average ROIC (7.41%) for SAN is below the current ROIC(13.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SAN's Profit Margin of 20.63% is fine compared to the rest of the industry. SAN outperforms 80.00% of its industry peers.
  • SAN's Profit Margin has declined in the last couple of years.
  • SAN's Operating Margin of 23.61% is in line compared to the rest of the industry. SAN outperforms 56.36% of its industry peers.
  • In the last couple of years the Operating Margin of SAN has grown nicely.
  • SAN has a Gross Margin (72.29%) which is in line with its industry peers.
  • SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
  • SAN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SAN has less shares outstanding
  • Compared to 1 year ago, SAN has a worse debt to assets ratio.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • SAN has a Debt to Equity ratio of 0.18. This is in the better half of the industry: SAN outperforms 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.71
WACC7.8%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SAN has a Current Ratio of 1.06. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • SAN has a worse Current ratio (1.06) than 72.73% of its industry peers.
  • A Quick Ratio of 0.30 indicates that SAN may have some problems paying its short term obligations.
  • The Quick ratio of SAN (0.30) is worse than 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for SAN have decreased by -8.39% in the last year.
  • SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.37% yearly.
  • SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.49%.
  • SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.57% yearly.
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%

3.2 Future

  • SAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.19% yearly.
  • The Revenue is expected to grow by 5.52% on average over the next years.
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • SAN is valuated reasonably with a Price/Earnings ratio of 11.52.
  • Compared to the rest of the industry, the Price/Earnings ratio of SAN indicates a rather cheap valuation: SAN is cheaper than 87.27% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, SAN is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.59, the valuation of SAN can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, SAN is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of SAN to the average of the S&P500 Index (27.20), we can say SAN is valued rather cheaply.
Industry RankSector Rank
PE 11.52
Fwd PE 9.59
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • SAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of SAN may justify a higher PE ratio.
  • A more expensive valuation may be justified as SAN's earnings are expected to grow with 12.69% in the coming years.
PEG (NY)0.57
PEG (5Y)3.41
EPS Next 2Y12.73%
EPS Next 3Y12.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • SAN has a Yearly Dividend Yield of 5.35%, which is a nice return.
  • SAN's Dividend Yield is rather good when compared to the industry average which is at 1.95. SAN pays more dividend than 94.55% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

  • The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 34.36% of the earnings are spent on dividend by SAN. This is a low number and sustainable payout ratio.
  • The dividend of SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.36%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

EPA:SAN (2/5/2026, 7:00:00 PM)

81.09

-0.75 (-0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap195.86B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts79.31
Price Target101.26 (24.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-4.87%
PT rev (3m)-4.86%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-2.58%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 11.52
Fwd PE 9.59
P/S 2.93
P/FCF N/A
P/OCF N/A
P/B 2.67
P/tB 44.55
EV/EBITDA N/A
EPS(TTM)7.04
EY8.68%
EPS(NY)8.45
Fwd EY10.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)0.57
PEG (5Y)3.41
Graham Number69.32
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.8%
ROIC/WACC1.71
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y10.94%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SAN.PA) has a profitability rating of 6 / 10.


What is the valuation of SANOFI based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 11.52 and the Price/Book (PB) ratio is 2.67.


How financially healthy is SANOFI?

The financial health rating of SANOFI (SAN.PA) is 3 / 10.